Mike Wilson, the firm's chief investment officer, predicted a slump for U.S. equities in the first half of 2025.
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target hoisted by equities researchers at Morgan Stanley from $123.00 to $130.00 in a research note issued to investors on ...
Intel (NASDAQ:INTC) just sent its stock soaring after-hours – up more than 10% – all thanks to a big leadership shake-up. The company announced ...
Wall Street tumbled 10% below its record for first "correction" since 2023 on Trump's trade war. The post appeared first on ...
Afya (NASDAQ:AFYA – Get Free Report) was downgraded by investment analysts at Morgan Stanley from an “equal weight” rating to ...
Morgan Stanley (Symbol: MS) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by ...
A Morgan Stanley analyst identifies the point where investors might find an attractive entry point to get back in the market.
Shares of Apple Inc. (NASDAQ:AAPL – Get Free Report) dropped 2.5% on Wednesday after Morgan Stanley lowered their price ...